Galapagos, Gilead Reach Deal Linked to Ouro Buy Galapagos and Gilead struck a deal on Mar 31, 2026 (Seeking Alpha). The linkage to Ouro Medicines raises questions about milestone timing and contingent payments for GLPG and GILD.

Galapagos, Gilead Reach Deal Linked to Ouro Buy: Galapagos and Gilead struck a deal on Mar 31, 2026 (Seeking Alpha). The linkage to Ouro Medicines raises questions about milestone timing and contingent payments for GLPG and… 👈 Read full analysis #Galapagos #Gilead #OuroMedicines #Biotech #Pharma

Gilead Agrees to Buy Ouro for Up to $2.18B Gilead announced on Mar 23, 2026 a deal valued at up to $2.18bn for Ouro Medicines (Investing.com); transaction signals targeted pipeline replenishment and requires close scrutiny of upfront vs milestone split.

Gilead Agrees to Buy Ouro for Up to $2.18B: Gilead announced on Mar 23, 2026 a deal valued at up to $2.18bn for Ouro Medicines (Investing.com); transaction signals targeted pipeline replenishment and… 👈 Read full analysis #Gilead #OuroMedicines #Pharmaceuticals #MergersAndAcquisitions #Biotech

Gilead Nears $2bn Ouro Medicines Deal Gilead is reported to be nearing a $2.0bn acquisition of Ouro Medicines (FT, Mar 23, 2026); the deal would be a targeted bolt-on versus Gilead's $21bn Immunomedics purchase in 2020.

Gilead Nears $2bn Ouro Medicines Deal: Gilead is reported to be nearing a $2.0bn acquisition of Ouro Medicines (FT, Mar 23, 2026); the deal would be a targeted bolt-on versus Gilead's $21bn Immunomedics purchase in… 👈 Read full analysis #Gilead #OuroMedicines #Acquisition #PharmaNews #Healthcare